DK107162C - Fremgangsmåde til fremstilling af 3-enol-ethere af 2-formyl-3-oxo-5α-steroider. - Google Patents

Fremgangsmåde til fremstilling af 3-enol-ethere af 2-formyl-3-oxo-5α-steroider.

Info

Publication number
DK107162C
DK107162C DK36763AA DK36763A DK107162C DK 107162 C DK107162 C DK 107162C DK 36763A A DK36763A A DK 36763AA DK 36763 A DK36763 A DK 36763A DK 107162 C DK107162 C DK 107162C
Authority
DK
Denmark
Prior art keywords
steroids
formyl
oxo
preparation
enol ethers
Prior art date
Application number
DK36763AA
Other languages
English (en)
Original Assignee
British Drug Houses Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Drug Houses Ltd filed Critical British Drug Houses Ltd
Application granted granted Critical
Publication of DK107162C publication Critical patent/DK107162C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Electric Cables (AREA)
  • Insulated Conductors (AREA)
DK36763AA 1962-01-26 1963-01-25 Fremgangsmåde til fremstilling af 3-enol-ethere af 2-formyl-3-oxo-5α-steroider. DK107162C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3001/62A GB1005639A (en) 1962-01-26 1962-01-26 2(3)-unsaturated 3-enol ethers of 2-formyl-3-oxo-5ª‡-steroids and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK107162C true DK107162C (da) 1967-05-01

Family

ID=9750081

Family Applications (2)

Application Number Title Priority Date Filing Date
DK37063AA DK109326C (da) 1962-01-26 1963-01-25 Fremgangsmåde til fremstilling af 3-enol-ethere af 2-hydroxymethyl-3-oxo-5α-steroider.
DK36763AA DK107162C (da) 1962-01-26 1963-01-25 Fremgangsmåde til fremstilling af 3-enol-ethere af 2-formyl-3-oxo-5α-steroider.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK37063AA DK109326C (da) 1962-01-26 1963-01-25 Fremgangsmåde til fremstilling af 3-enol-ethere af 2-hydroxymethyl-3-oxo-5α-steroider.

Country Status (8)

Country Link
US (2) US3160643A (da)
BR (1) BR6346445D0 (da)
CH (1) CH451126A (da)
DE (1) DE1443466A1 (da)
DK (2) DK109326C (da)
FR (2) FR1572954A (da)
GB (1) GB1005639A (da)
NO (1) NO123131B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415852A (en) * 1965-08-20 1968-12-10 American Cyanamid Co Method of preparing 3-alkoxy-2-formyl-delta2-steroids and new products resulting therefrom
US3562260A (en) * 1965-08-23 1971-02-09 Ormonoterapia Richter Spa 2-carbonyl-estratrienes and method of their preparation

Also Published As

Publication number Publication date
CH451126A (de) 1968-05-15
NO123131B (da) 1971-10-04
BR6346445D0 (pt) 1973-07-03
FR1572954A (da) 1969-07-04
DE1443466A1 (de) 1969-01-30
FR1572107A (da) 1969-06-27
GB1005639A (en) 1965-09-22
US3155692A (en) 1964-11-03
US3160643A (en) 1964-12-08
DK109326C (da) 1968-04-16

Similar Documents

Publication Publication Date Title
DK115403B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.
DK104168C (da) Fremgangsmåde til fremstilling af mono-biguanider.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK108976C (da) Fremgangsmåde til fremstilling af hendecapeptider.
DK109336C (da) Fremgangsmåde til fremstilling af glycidylethere.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK107027C (da) Fremgangsmåde til fremstilling af 3-hydroxy-benzisoxazoler.
DK109326C (da) Fremgangsmåde til fremstilling af 3-enol-ethere af 2-hydroxymethyl-3-oxo-5α-steroider.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK106184C (da) Fremgangsmåde til fremstilling af alkylaralkylftalater.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK104136C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider.
DK104347C (da) Fremgangsmåde til fremstilling af 16α-hydroxysteroider.
DK104055C (da) Fremgangsmåde til fremstilling af 6-methoxytetraloner.
DK105463C (da) Fremgangsmåde til fremstilling af 10-alkyl-3-keto-steroider.
DK108795C (da) Fremgangsmåde til fremstilling af 2-ureido-2-furanacetonitril.
DK103505C (da) Fremgangsmåde til fremstilling af 4-N-demethyl-4-N-ethyl-oxytetracyclin.
DK108624C (da) Fremgangsmåde til fremstilling af 1α-metylcorticoider.
DK108027C (da) Fremgangsmåde til fremstilling af glucuronamider.
DK102351C (da) Fremgangsmåde til fremstilling af α-aminobenzylpenicillin.
DK101983C (da) Fremgangsmåde til fremstilling af 1-hydroxymethylcolchicin.